These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 36901822)

  • 1. The Role of Alpha-Synuclein Deposits in Parkinson's Disease: A Focus on the Human Retina.
    Di Pippo M; Fragiotta S; Di Staso F; Scuderi L; Abdolrahimzadeh S
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylated α-synuclein in the retina is a biomarker of Parkinson's disease pathology severity.
    Ortuño-Lizarán I; Beach TG; Serrano GE; Walker DG; Adler CH; Cuenca N
    Mov Disord; 2018 Aug; 33(8):1315-1324. PubMed ID: 29737566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated accumulation of retinal α-synuclein (pSer129) and tau, neuroinflammation, and autophagic dysregulation in a seeded mouse model of Parkinson's disease.
    Mammadova N; Summers CM; Kokemuller RD; He Q; Ding S; Baron T; Yu C; Valentine RJ; Sakaguchi DS; Kanthasamy AG; Greenlee JJ; Heather West Greenlee M
    Neurobiol Dis; 2019 Jan; 121():1-16. PubMed ID: 30218757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal α-synuclein deposits in Parkinson's disease patients and animal models.
    Veys L; Vandenabeele M; Ortuño-Lizarán I; Baekelandt V; Cuenca N; Moons L; De Groef L
    Acta Neuropathol; 2019 Mar; 137(3):379-395. PubMed ID: 30721408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retina as a Model to Study In Vivo Transmission of α-Synuclein in the A53T Mouse Model of Parkinson's Disease.
    Mammadova N; Baron T; Verchère J; Greenlee JJ; Greenlee MHW
    Methods Mol Biol; 2021; 2224():75-85. PubMed ID: 33606207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine, Alpha-Synuclein, and Mitochondrial Dysfunctions in Parkinsonian Eyes.
    Indrieri A; Pizzarelli R; Franco B; De Leonibus E
    Front Neurosci; 2020; 14():567129. PubMed ID: 33192254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retina-to-brain spreading of α-synuclein after intravitreal injection of preformed fibrils.
    Pérez-Acuña D; Rhee KH; Shin SJ; Ahn J; Lee JY; Lee SJ
    Acta Neuropathol Commun; 2023 May; 11(1):83. PubMed ID: 37210559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal live imaging of retinal α-synuclein::GFP deposits in a transgenic mouse model of Parkinson's Disease/Dementia with Lewy Bodies.
    Price DL; Rockenstein E; Mante M; Adame A; Overk C; Spencer B; Duong-Polk KX; Bonhaus D; Lindsey J; Masliah E
    Sci Rep; 2016 Jul; 6():29523. PubMed ID: 27389831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translational molecular imaging and drug development in Parkinson's disease.
    Haider A; Elghazawy NH; Dawoud A; Gebhard C; Wichmann T; Sippl W; Hoener M; Arenas E; Liang SH
    Mol Neurodegener; 2023 Feb; 18(1):11. PubMed ID: 36759912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The central theme of Parkinson's disease: α-synuclein.
    Ozansoy M; Başak AN
    Mol Neurobiol; 2013 Apr; 47(2):460-5. PubMed ID: 23180276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated α-synuclein and NfL levels in tear fluids and decreased retinal microvascular densities in patients with Parkinson's disease.
    Lin CW; Lai TT; Chen SJ; Lin CH
    Geroscience; 2022 Jun; 44(3):1551-1562. PubMed ID: 35484471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α-Synuclein in the olfactory system in Parkinson's disease: role of neural connections on spreading pathology.
    Ubeda-Bañon I; Saiz-Sanchez D; de la Rosa-Prieto C; Martinez-Marcos A
    Brain Struct Funct; 2014 Sep; 219(5):1513-26. PubMed ID: 24135772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral defects associated with amygdala and cortical dysfunction in mice with seeded α-synuclein inclusions.
    Stoyka LE; Arrant AE; Thrasher DR; Russell DL; Freire J; Mahoney CL; Narayanan A; Dib AG; Standaert DG; Volpicelli-Daley LA
    Neurobiol Dis; 2020 Feb; 134():104708. PubMed ID: 31837424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson's Disease: What Can Retinal Imaging Tell Us?
    Di Pippo M; d'Agostino S; Ruggeri F; Carrozzi C; Fasciolo D; Abdolrahimzadeh S
    J Integr Neurosci; 2024 Jan; 23(1):23. PubMed ID: 38287853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How can rAAV-α-synuclein and the fibril α-synuclein models advance our understanding of Parkinson's disease?
    Volpicelli-Daley LA; Kirik D; Stoyka LE; Standaert DG; Harms AS
    J Neurochem; 2016 Oct; 139 Suppl 1(Suppl 1):131-155. PubMed ID: 27018978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of α-Synuclein in Parkinson's Disease: From a Neuron-Glia Crosstalk Perspective.
    Yi S; Wang L; Wang H; Ho MS; Zhang S
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of retinal architecture in Parkinson's disease.
    Chorostecki J; Seraji-Bozorgzad N; Shah A; Bao F; Bao G; George E; Gorden V; Caon C; Frohman E; Bhatti MT; Khan O
    J Neurol Sci; 2015 Aug; 355(1-2):44-8. PubMed ID: 26071887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting alpha-synuclein for the treatment of Parkinson's disease.
    Rohn TT
    CNS Neurol Disord Drug Targets; 2012 Mar; 11(2):174-9. PubMed ID: 22483285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structures of α-synuclein filaments from human brains with Lewy pathology.
    Yang Y; Shi Y; Schweighauser M; Zhang X; Kotecha A; Murzin AG; Garringer HJ; Cullinane PW; Saito Y; Foroud T; Warner TT; Hasegawa K; Vidal R; Murayama S; Revesz T; Ghetti B; Hasegawa M; Lashley T; Scheres SHW; Goedert M
    Nature; 2022 Oct; 610(7933):791-795. PubMed ID: 36108674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.